Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Decreased appetite, Gait disturbance, Gastrointestinal pain
Clinical narrative: Low Grade Fever; low back pain; Little appetite; Muscle soreness; Migraine like headache; Joint aches particularly hand and feet; Soreness in hands and feet; Difficulty Walking; GI Light cramping; This is a Spontaneous report from a contactable Other HCP (nurse reported for herself). A 67-year-old female patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, formulation: solution for injection, Lot Number: EM9810), dose 2 via an unspecified route of administration, administered in Arm Right on 22Feb2021 at 10:00 AM (at the age of 67-year-old) as DOSE 2, SINGLE for covid-19 immunisation. Additional Vaccines Administered on Same Date of the Pfizer Suspect was none. Medical history included hypothyroidism from an unknown date and unknown if ongoing. The patient was not a smoker/former smoker. No family Medical History Relevant to AE(s). Concomitant medication(s) included Levothyroxine sodium (SYNTHROID) (been on it for about 20 years, since she was 40) taken for hypothyroidism, start and stop date were not reported. The patient historical vaccine included Prolia injections which She previously took every 6 months but was not around time of vaccination, she stated she was due now it has been 6 months. No other details provided for medication. The patient previously took her first dose of bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, formulation: solution for injection, Lot Number: EL9265), via an unspecified route of administration, administered in Arm Right on 01Feb2021 at 10:00 AM (at the age of 67-year-old), as single for covid-19 immunisation. No AE(s) following prior vaccinations. On 22Feb2021, it was about 6 hours post second injection, the patient experienced low grade fever, low back pain, little appetite, muscle soreness, migraine like headache, joint aches particularly hand and feet, soreness in hands and feet, difficulty walking and GI light cramping. The clinical details of the events as follows: It was about 6 hours post second injection; it was low grade fever. She stated she has completely recovered in 6 days, medically not significant, no hospitalizations, not alarming, totally uncomfortable, no MD appoints, self-care she took care of herself. she stated this is for every symptom, everything. She described herself as pretty hard core stating she has a high pain tolerance. She reported joint aches, particularly hand and feet, which she states was odd. She reported migraine like headache diagnosed in the 90s that is how she knew what the migraine felt like. She stated that she had difficulty walking and continues to mumble what sounds like of course it was difficult to walk if you feel like crap, but then stated to not document that. She asked if she had these symptoms because she was 90 pounds and Stated she always wonders if it was because of her weight. she stated she was very thankful, and it sounds like someday there will be a booster, so she will get prepared. She wishes to add, and everyone has this- site soreness on the first injection and a low-grade fever. It was reported that pharmacists said the vaccine was 95 percent effective, but she thought the vaccine was 99 percent. She stated she has no medical conditions, no blood pressure, no nothing. The patient has no positive test for SARS-CoV2. It was unknown if the patient has SARS-CoV2 antibodies at diagnosis. AE(s) did not require a visit to Emergency Room and Physician Office. No relevant tests were done. She took Tylenol 1000mg every evening for 5 nights, not around the clock, when asked lot/expiry, stated she believed the expiration may have been 2023 or 2024, it was way off, provided no other details. No Investigation Assessment was provided. Therapeutic measures were taken as a result of low-grade fever, low back pain, muscle soreness, migraine like headache, joint aches particularly hand and feet, soreness in hands and feet. The patient outcome of the events was resolved on 28Feb2021.  Source of assessment: Primary source Reporter/ Method of assessment: Global introspection/ Drug result: Related for the events of Low-grade Fever, low backpain, GI Light cramping, Little appetite, joint aches, Muscle soreness and Migraine like Headache.  No follow-up attempts are possible. No further information is expected.